OWC Pharmaceutical Research Corp (OWCP)

[GlobalTrader_OTC]

OWCP Looks to Bring Pharma-Grade Cannabis Therapeutics to Market!!!

There are many different companies active in the medical marijuana industry, but few of them are conducting clinical research trials in accord with the Helsinki Committee Institutional Review Board protocols. Most investors are familiar with GW Pharmaceuticals plc (NASDAQ: GWPH) and its Sativex® cannabinoid medicine for the treatment of multiple sclerosis symptoms and cancer pain indications, but OWC Pharmaceutical Research Corp. (OTCQB: OWCP) is a lesser known company operating in the burgeoning industry.

Based in Israel, an international tech and biotech hub, and the epicenter of medical cannabis research, the OWCP is conducting clinical trials of cannabis-based treatments for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder and migraines. The team is also working on several proprietary drug delivery mechanisms designed to provide consistent and reliable cannabinoid doses to patients more efficiently than smoking or consuming marijuana edibles.

Full Article below Please watch the interview: http://www.baystreet.ca/viewarticle.aspx?id=437873 .

99% of all CANNABIS RESEARCH IS BEING DONE IN ISREAL, OWCP IS AT THE EPICENTER OF THIS WORK


OWCP named one of top 20 Cannabis Stocks by Cannabis Investor Magazine!!!

Cannabis Investor Magazine June Top 20 Cannabis Stocks?